8-K

BRADY CORP (BRC)

8-K 2024-11-18 For: 2024-11-18
View Original
Added on April 04, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 18, 2024

BRADY CORPORATION

(Exact name of registrant as specified in its charter)

Commission File Number 1-14959

Wisconsin 39-0178960
(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)

6555 West Good Hope Road

Milwaukee, Wisconsin 53223

(Address of principal executive offices and Zip Code)

(414) 358-6600

(Registrant’s Telephone Number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per share BRC New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On November 18, 2024, Brady Corporation (the “Company”) issued a press release announcing its fiscal 2025 first quarter financial results. A copy of the press release is being furnished to the Securities and Exchange Commission as Exhibit 99.1 attached hereto and is incorporated herein by reference.

Item 7.01 REGULATION FD DISCLOSURE

On November 18, 2024, the Company hosted a conference call related to its fiscal 2025 first quarter financial results. A copy of the slides referenced in the conference call, which is also posted on the Corporation’s website, is being furnished to the Securities and Exchange Commission as Exhibit 99.2 attached hereto and is incorporated herein by reference.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

EXHIBIT NUMBER DESCRIPTION
99.1 Press Release of Brady Corporation, dated November 18, 2024, relating to first quarter fiscal 2025 financial results.
99.2 Informational slides provided by Brady Corporation, dated November 18, 2024, relating to first quarter fiscal 2025 financial results.
104 Cover Page Interactive Data File (embedded within Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BRADY CORPORATION
Date: November 18, 2024
/s/ ANN E. THORNTON
Ann E. Thornton
Chief Financial Officer, Chief Accounting Officer and Treasurer

Document

EXHIBIT 99.1

For More Information:

Investor contact: Ann Thornton 414-438-6887

Media contact: Kate Venne 414-358-5176

Brady Corporation Reports Fiscal 2025 First Quarter Results

•Sales for the quarter increased 13.6 percent. Organic sales increased 3.6 percent, acquisitions net of divestitures increased sales 8.8 percent, and foreign currency increased sales 1.2 percent.

•Income before income taxes was $58.8 million in the first quarter of fiscal 2025 compared to $59.4 million in the first quarter of fiscal 2024. Adjusted Income Before Income Taxes* in the first quarter of fiscal 2025 was $68.6 million compared to $61.8 million in the first quarter of fiscal 2024.

•Diluted EPS was $0.97 in the first quarter of both fiscal 2025 and 2024. Adjusted Diluted EPS* increased 12.0 percent to $1.12 in the first quarter of fiscal 2025 compared to $1.00 in the same quarter of the prior year.

MILWAUKEE (November 18, 2024) -- Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results for its fiscal 2025 first quarter ended October 31, 2024.

Quarter Ended October 31, 2024 Financial Results:

Sales for the quarter ended October 31, 2024 increased 13.6 percent, which consisted of an organic sales increase of 3.6 percent, an increase of 9.9 percent from acquisitions, an increase of 1.2 percent from foreign currency translation and a decrease of 1.1 percent from divestitures. Sales for the quarter ended October 31, 2024 were $377.1 million compared to $332.0 million in the same quarter last year. By region, sales increased 10.7 percent in the Americas & Asia and increased 19.3 percent in Europe & Australia, which included an organic sales increase of 5.1 percent in the Americas & Asia and an organic sales increase of 0.7 percent in Europe & Australia.

Income before income taxes decreased 1.0 percent to $58.8 million in the quarter ended October 31, 2024 compared to $59.4 million in the same quarter last year. Adjusted Income Before Income Taxes* in the quarter ended October 31, 2024, which was adjusted for amortization expense and other acquisition-related charges of $9.8 million, was $68.6 million, an increase of 11.0 percent compared to the first quarter of last year. Adjusted Income Before Income Taxes* in the quarter ended October 31, 2023, which was adjusted for amortization expense of $2.4 million, was $61.8 million.

Net income in the quarter ended October 31, 2024 was $46.8 million compared to $47.2 million in the same quarter last year. Earnings per diluted Class A Nonvoting Common Share were $0.97 in both the first quarter of fiscal 2025 and 2024. Adjusted Net Income* in the quarter ended October 31, 2024 was $54.2 million compared to $49.1 million in the same quarter last year. Adjusted Diluted EPS* in the quarter ended October 31, 2024 was $1.12.

Commentary:

“Our investments in our sales force and in research and development are paying off as we grew sales organically in both of our regions this quarter, and we have more innovative new products planned for launch in 2025,” said Brady’s President and CEO, Russell R. Shaller. “This quarter we also completed our acquisition of Gravotech, adding an exciting new solution to our offerings. Gravotech designs and manufactures specialized laser and mechanical engravers, which enhances our identification product portfolio and allows us to provide precision direct part marking solutions. I’m looking forward to our collaborative new product development plans in 2025.”

“We generated adjusted EPS of $1.12 this quarter, which represented 12.0 percent growth compared to the first quarter of last year,” said Brady’s Chief Financial Officer, Ann Thornton. “This strong performance was driven by organic sales growth and continued gross margin expansion in our organic business. Even after investing $140.6 million in acquisitions in the first quarter, we remain in a net cash position of $29.0 million as of October 31, 2024. Our strong balance sheet, strategic investments in organic and inorganic opportunities, and continued cash generation position us to drive shareholder value into the future.”

Fiscal 2025 Guidance:

The Company’s Adjusted Diluted EPS* guidance for the year ending July 31, 2025 remains unchanged at $4.40 to $4.70 per share, and the Company’s GAAP earnings per diluted Class A Nonvoting Common Share guidance for the year ending July 31, 2025 was updated for amortization and other acquisition-related charges to $4.02 to $4.32 per share.

The other assumptions included in our fiscal 2025 guidance are effectively unchanged. We expect a full-year income tax rate of approximately 20 percent, depreciation and amortization expense of approximately $40 million, and capital expenditures of approximately $35 million. Our fiscal 2025 guidance is based on foreign currency exchange rates as of October 31, 2024 and assumes continued economic growth.

A webcast regarding Brady’s fiscal 2025 first quarter financial results will be available at www.bradycorp.com/investors beginning at 9:30 a.m. central time today.

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2024, employed approximately 5,700 people in its worldwide businesses. Brady’s fiscal 2024 sales were approximately $1.34 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradyid.com.

* Adjusted Income Before Income Taxes, Adjusted Net Income, and Adjusted Diluted EPS are non-GAAP measures. See appendix for more information on these measures, including reconciliations to the most directly comparable GAAP measures.

In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of raw materials and labor as well as material shortages and supply chain disruptions; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady’s ability to identify, integrate and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting our websites, networks, and systems against security breaches; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; global climate change and environmental regulations; litigation, including product liability claims; foreign currency fluctuations; changes in tax legislation and tax rates; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2024.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

BRADY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited; Dollars in thousands, except per share data)

Three months ended October 31,
2024 2023
Net sales $ 377,065 $ 331,983
Cost of goods sold 187,376 160,264
Gross margin 189,689 171,719
Operating expenses:
Research and development 18,921 15,702
Selling, general and administrative 111,846 96,287
Total operating expenses 130,767 111,989
Operating income 58,922 59,730
Other income (expense):
Investment and other income (expense) 1,234 438
Interest expense (1,356) (766)
Income before income taxes 58,800 59,402
Income tax expense 12,017 12,161
Net income $ 46,783 $ 47,241
Net income per Class A Nonvoting Common Share:
Basic $ 0.98 $ 0.97
Diluted $ 0.97 $ 0.97
Net income per Class B Voting Common Share:
Basic $ 0.96 $ 0.96
Diluted $ 0.95 $ 0.95
Weighted average common shares outstanding:
Basic 47,732 48,505
Diluted 48,217 48,811

BRADY CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

October 31, 2024 July 31, 2024
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 145,661 $ 250,118
Accounts receivable, net of allowance for credit losses of $10,295 and $6,749, respectively 218,258 185,486
Inventories 178,688 152,729
Prepaid expenses and other current assets 13,462 11,382
Total current assets 556,069 599,715
Property, plant and equipment—net 201,374 195,758
Goodwill 671,705 589,611
Other intangible assets 116,369 51,839
Deferred income taxes 16,841 15,596
Operating lease assets 42,157 38,504
Other assets 23,361 24,546
Total $ 1,627,876 $ 1,515,569
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 98,179 $ 84,691
Accrued compensation and benefits 65,004 77,954
Taxes, other than income taxes 22,901 14,061
Accrued income taxes 11,994 7,424
Current operating lease liabilities 13,120 13,382
Other current liabilities 90,272 67,170
Total current liabilities 301,470 264,682
Long-term debt 116,645 90,935
Long-term operating lease liabilities 29,201 25,342
Other liabilities 71,628 67,952
Total liabilities 518,944 448,911
Stockholders’ equity:
Common stock:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 44,223,664 and 44,042,462 shares, respectively 513 513
Class B voting common stock—Issued and outstanding, 3,538,628 shares 35 35
Additional paid-in capital 354,592 353,654
Retained earnings 1,209,406 1,174,025
Treasury stock—7,037,823 and 7,219,025 shares, respectively, of Class A nonvoting common stock, at cost (344,012) (351,947)
Accumulated other comprehensive loss (111,602) (109,622)
Total stockholders’ equity 1,108,932 1,066,658
Total $ 1,627,876 $ 1,515,569

BRADY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; Dollars in thousands)

Three months ended October 31,
2024 2023
Operating activities:
Net income $ 46,783 $ 47,241
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 10,164 7,466
Stock-based compensation expense 5,813 4,163
Deferred income taxes (903) (2,225)
Other (880) 1,137
Changes in operating assets and liabilities:
Accounts receivable (4,385) (2,205)
Inventories (2,107) 6,152
Prepaid expenses and other assets (1,136) (1,488)
Accounts payable and accrued liabilities (33,960) (3,725)
Income taxes 4,017 5,757
Net cash provided by operating activities 23,406 62,273
Investing activities:
Purchases of property, plant and equipment (7,286) (11,279)
Acquisition of businesses, net of cash acquired (140,625)
Other 10
Net cash used in investing activities (147,901) (11,279)
Financing activities:
Payment of dividends (11,402) (11,338)
Proceeds from exercise of stock options 5,855 2,598
Payments for employee taxes withheld from stock-based awards (2,090) (2,333)
Purchase of treasury stock (14,121)
Proceeds from borrowing on credit facilities 135,149 38,551
Repayment of borrowing on credit facilities (109,439) (36,000)
Other 190 1,149
Net cash used in financing activities 18,263 (21,494)
Effect of exchange rate changes on cash 1,775 (5,680)
Net (decrease) increase in cash and cash equivalents (104,457) 23,820
Cash and cash equivalents, beginning of period 250,118 151,532
Cash and cash equivalents, end of period $ 145,661 $ 175,352

BRADY CORPORATION AND SUBSIDIARIES

SEGMENT INFORMATION

(Unaudited; Dollars in thousands)

Three months ended October 31,
2024 2023
NET SALES
Americas & Asia $ 245,428 $ 221,626
Europe & Australia 131,637 110,357
Total $ 377,065 $ 331,983
SALES INFORMATION
Americas & Asia
Organic 5.1 % 3.3 %
Acquisitions 7.4 % %
Currency (0.2) % %
Divestiture (1.6) % (1.9) %
Total 10.7 % 1.4 %
Europe & Australia
Organic 0.7 % 1.4 %
Acquisitions 15.0 % %
Currency 3.6 % 4.6 %
Total 19.3 % 6.0 %
Total Company
Organic 3.6 % 2.7 %
Acquisitions 9.9 % %
Currency 1.2 % 1.5 %
Divestiture (1.1) % (1.3) %
Total 13.6 % 2.9 %
SEGMENT PROFIT
Americas & Asia $ 54,900 $ 49,897
Europe & Australia 13,114 16,744
Total segment profit $ 68,014 $ 66,641
SEGMENT PROFIT AS A PERCENT OF NET SALES
Americas & Asia 22.4 % 22.5 %
Europe & Australia 10.0 % 15.2 %
Total 18.0 % 20.1 % Three months ended October 31,
--- --- --- --- --- --- ---
2024 2023
Total segment profit $ 68,014 $ 66,641
Unallocated amounts:
Administrative costs (9,092) (6,911)
Investment and other income 1,234 438
Interest expense (1,356) (766)
Income before income taxes $ 58,800 $ 59,402

GAAP to NON-GAAP MEASURES

(Unaudited; Dollars in Thousands, Except Per Share Amounts)

In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.

Adjusted Income Before Income Taxes:

Brady is presenting the non-GAAP measure, "Adjusted Income Before Income Taxes." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Adjusted Income Before Income Taxes:

Three months ended October 31,
2024 2023
Income before income taxes (GAAP measure) $ 58,800 $ 59,402
Amortization expense 4,713 2,355
Non-recurring acquisition-related costs and other expenses 5,059
Adjusted Income Before Income Taxes (non-GAAP measure) $ 68,572 $ 61,757

Adjusted Income Tax Expense:

Brady is presenting the non-GAAP measure, "Adjusted Income Tax Expense." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Adjusted Income Tax Expense:

Three months ended October 31,
2024 2023
Income tax expense (GAAP measure) $ 12,017 $ 12,161
Amortization expense 1,133 546
Non-recurring acquisition-related costs and other expenses 1,265
Adjusted Income Tax Expense (non-GAAP measure) $ 14,415 $ 12,707

Adjusted Net Income:

Brady is presenting the non-GAAP measure, "Adjusted Net Income." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Adjusted Net Income:

Three months ended October 31,
2024 2023
Net income (GAAP measure) $ 46,783 $ 47,241
Amortization expense 3,580 1,809
Non-recurring acquisition-related costs and other expenses 3,794
Adjusted Net Income (non-GAAP measure) $ 54,157 $ 49,050

Adjusted Diluted EPS:

Brady is presenting the non-GAAP measure, "Adjusted Diluted EPS." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Adjusted Diluted EPS (Note that certain amounts will not foot due to rounding):

Three months ended October 31,
2024 2023
Net income per Class A Nonvoting Common Share (GAAP measure) $ 0.97 $ 0.97
Amortization expense 0.07 0.04
Non-recurring acquisition-related costs and other expenses 0.08
Adjusted Diluted EPS (non-GAAP measure) $ 1.12 $ 1.00

Adjusted Diluted EPS Guidance:

Fiscal 2025 Expectations
Low High
Earnings per Class A Nonvoting Common Share (GAAP measure) $ 4.02 $ 4.32
Amortization expense 0.30 0.30
Non-recurring acquisition-related costs and other expenses 0.08 0.08
Adjusted Diluted EPS (non-GAAP measure) $ 4.40 $ 4.70

f25q1conferencecallprese

F’25 Q1 Financial Results Brady Corporation November 18, 2024


Forward-Looking Statements In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations. The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of raw materials and labor as well as raw material shortages and supply chain disruptions; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady’s ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting our websites, networks and systems against security breaches; risks associated with the loss of key employees; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; global climate change and environmental regulations; litigation, including product liability claims; foreign currency fluctuations; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; changes in tax legislation and tax rates; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2024. These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward- looking statements. Brady does not undertake to update its forward-looking statements except as required by law. 2


Q1 F’25 Highlights 3 * Adjusted Diluted Earnings per Share is a non-GAAP measure. See appendix. Organic sales growth of 3.6%. Americas & Asia organic sales growth of 5.1%. Europe & Australia organic sales growth of 0.7%. Acquisition growth of 9.9%. Sales Growth GPM of 50.3% compared to 51.7% in Q1 of F’24. Gross profit includes purchase accounting adjustments related to the acquisition of Gravotech. Gross Profit Margin GAAP EPS of $0.97 was consistent with Q1 of last year. Adjusted Diluted Earnings per Share* increased 12.0% to $1.12 in Q1 of F’25 compared to $1.00 in Q1 of F’24. Growth in Adjusted Diluted Earnings per Share* Acquired businesses for $140.6M. Paid dividends of $11.4M. In a net cash position of $29.0M at October 31, 2024. Returning Capital to our Shareholders


Sales Overview 4 Q1 F’25 SALES: Total sales increased 13.6%. Organic sales increased 3.6%. • Americas & Asia – Organic sales increased 5.1%. • Europe & Australia – Organic sales increased 0.7%. Foreign currency translation increased sales 1.2%. Acquisitions net of divestitures increased sales 8.8%. $321 $318 $339 $324 $323 $326 $337 $346 $332 $323 $343 $343 $377 $225 $250 $275 $300 $325 $350 $375 Q1 F'22 7.0% Q2 F'22 13.1% Q3 F'22 9.0% Q4 F'22 9.0% Q1 F'23 6.9% Q2 F'23 6.3% Q3 F'23 1.9% Q4 F'23 6.9% Q1 F'24 2.7% Q2 F'24 1.6% Q3 F'24 4.5% Q4 F'24 1.6% Q1 F'25 3.6%Organic Growth SALES (millions of USD) Q1 F’25 SALES COMMENTARY: Organic sales grew 5.0% in the Americas with growth in all major product lines. Asia organic sales grew 6.3% with growth across the region offsetting a decline in organic sales in China. Organic sales grew 1.1% in Europe with growth in safety and facility identification and people identification. Australia organic sales declined 1.9%.


Gross Profit Margin 5 $155 $149 $164 $163 $155 $156 $170 $176 $172 $162 $177 $177 $190 48.2% 47.0% 48.4% 50.4% 48.1% 48.0% 50.3% 50.8% 51.7% 50.2% 51.6% 51.6% 50.3% 38% 40% 42% 44% 46% 48% 50% 52% $100 $125 $150 $175 $200 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 GROSS PROFIT & GPM% (millions of USD) Q1 F’25 – GROSS PROFIT MARGIN: Gross profit margin of 50.3% compared to 51.7% in Q1 of F’24. The non-recurring impact of purchase accounting charges related to our acquisition of Gravotech reduced our gross profit margin by approximately 110 basis points. Inflation continues, but we are experiencing a reduced rate of inflation in most geographies.


SG&A Expense 6 Q1 F’25 – SG&A EXPENSE: SG&A expense increased as a percent of sales when compared to Q1 last year primarily due to increased amortization and other acquisition-related expenses. Inflation continues in certain geographies. We continue to focus on identifying and executing sustainable efficiency gains in order to offset cost increases, while making the necessary investments to drive future sales growth. $97 $93 $96 $95 $90 $92 $91 $97 $96 $91 $96 $93 $112 30.1% 29.1% 28.4% 29.2% 27.9% 28.3% 27.0% 28.2% 29.0% 28.3% 27.9% 27.2% 29.7% 10% 15% 20% 25% 30% 35% $60 $70 $80 $90 $100 $110 $120 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 SG&A EXPENSE AND SG&A EXPENSE AS A % OF SALES (millions of USD)


R&D Expense 7 Q1 F’25 – R&D EXPENSE: We remain committed to our investments in R&D in order to drive profitable long-term sales growth. We are focused on ensuring that our R&D spend is both efficient and effective. $13.9 $14.0 $14.9 $15.8 $13.9 $15.4 $15.7 $16.3 $15.7 $16.8 $17.7 $17.5 $18.9 4.3% 4.4% 4.4% 4.9% 4.3% 4.7% 4.7% 4.7% 4.7% 5.2% 5.1% 5.1% 5.0% 1.5% 2.5% 3.5% 4.5% 5.5% $8.0 $10.0 $12.0 $14.0 $16.0 $18.0 $20.0 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 R&D EXPENSE AND R&D EXPENSE AS A % OF SALES (millions of USD)


Income Before Income Taxes 8 $44.7 $42.0 $51.3 $54.0 $50.3 $48.5 $63.0 $63.8 $59.4 $55.8 $64.4 $68.2 $58.8 $10 $20 $30 $40 $50 $60 $70 Q1 F'22 5.8% Q2 F'22 6.7% Q3 F'22 7.3% Q4 F'22 29.7% Q1 F'23 12.6% Q2 F'23 15.4% Q3 F'23 23.0% Q4 F'23 18.2% Q1 F'24 18.0% Q2 F'24 15.1% Q3 F'24 2.2% Q4 F'24 6.9% Q1 F'25 (1.0%) * Adjusted Income Before Income Taxes is a non-GAAP measure. See appendix. (millions of USD)INCOME BEFORE INCOME TAXES (GAAP) Q1 F’25 – INCOME BEFORE INCOME TAXES: GAAP Income before income taxes was down 1.0% to $58.8M in Q1 of F’25 compared to $59.4M in Q1 of F’24. Excluding adjusted* items from both periods, income before income taxes was up 11.0% to $68.6M in Q1 of F’25 compared to $61.8M in Q1 of F’24. Year-on-Year Growth (Decline)


Net Income & Diluted EPS 9 Q1 F’25 – NET INCOME & DILUTED EPS: GAAP Net Income was $46.8M in Q1 of F’25 compared to $47.2M in Q1 of F’24 (a decrease of 1.0%). • Adjusted Net Income* was $54.2M in Q1 of F’25 compared to $49.1M in Q1 of F’24 (an increase of 10.4%). GAAP Diluted EPS was $0.97 in Q1 of F’25 and in Q1 of F’24. • Adjusted Diluted EPS* was $1.12 in Q1 of F’25 compared to $1.00 in Q1 of F’24 (an increase of 12.0%). * Adjusted Net Income and Adjusted Diluted EPS are non-GAAP measures. See appendix. $35.0 $33.8 $40.1 $41.1 $39.4 $38.0 $48.1 $49.4 $47.2 $43.6 $50.9 $55.5 $46.8 $20 $30 $40 $50 $60 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 NET INCOME (GAAP) (millions of USD) $0.67 $0.65 $0.78 $0.81 $0.79 $0.76 $0.96 $1.00 $0.97 $0.90 $1.05 $1.15 $0.97 $0.20 $0.40 $0.60 $0.80 $1.00 $1.20 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 DILUTED EPS (GAAP)


Cash Generation 10 CASH FLOW FROM OPERATING ACTIVITIES $27.5 ($3.2) $40.9 $53.2 $28.0 $29.4 $72.5 $79.3 $62.3 $36.1 $72.7 $84.0 $23.4 -$5 $20 $45 $70 $95 Q1 F'22 78% Q2 F'22 (9%) Q3 F'22 102% Q4 F'22 130% Q1 F'23 71% Q2 F'23 77% Q3 F'23 151% Q4 F'23 161% Q1 F'24 132% Q2 F'24 83% Q3 F'24 143% Q4 F'24 151% Q1 F'25 50%% of Net Income CASH FLOWS IN Q1 OF F’25: Overview: Cash flow from operating activities was $23.4M in Q1 of F’25 vs. $62.3M in Q1 of F’24. Free cash flow* was $16.1M in Q1 of F’25 compared to $51.0M in Q1 of F’24. We invested $140.6M in acquisitions in Q1 of F’25. We returned $11.4M to our shareholders in the form of dividends. * Free cash flow is calculated as Net Cash Provided by Operating Activities less Capital Expenditures. (millions of USD) (millions of USD) 3 Mos. Ended Oct. 31, 2024 3 Mos. Ended Oct. 31, 2023 Cash Balance - Beginning of Period 250.1$ 151.5$ Cash Flow from Operating Activities 23.4 62.3 Capital Expenditures (7.3) (11.3) Dividends (11.4) (11.3) Share Repurchases - (14.1) Business Acquisitions (140.6) - Debt Borrowings / (Repayments) 25.7 2.6 Effect of Exchange Rates on Cash 1.8 (5.7) Other 4.0 1.5 Cash Balance - End of Period 145.7$ 175.4$


Net Cash 11 STRONG BALANCE SHEET: October 31, 2024 cash = $145.7M. October 31, 2024 debt = $116.6M. Balance sheet provides flexibility for future organic and inorganic investments. $91 $64 $26 $19 $15 $31 $84 $102 $123 $96 $97 $159 $29 $0 $50 $100 $150 $200 $250 $300 $350 Q1 F'22 Q2 F'22 Q3 F'22 Q4 F'22 Q1 F'23 Q2 F'23 Q3 F'23 Q4 F'23 Q1 F'24 Q2 F'24 Q3 F'24 Q4 F'24 Q1 F'25 NET CASH (millions of USD)


F’25 Diluted EPS Guidance GAAP Diluted EPS $4.02 to $4.32 F’25 Adjusted Diluted EPS* $4.40 to $4.70 Guidance Assumptions: Organic sales growth in the low-single digit percentages. Full-year income tax rate of approximately 20%. Foreign currency exchange rates as of October 31, 2024. Depreciation and amortization expense of approximately $40M. Capital expenditures of approximately $35M. Adjusted Diluted EPS guidance represents a range of 4.3% growth to 11.4% growth vs. F’24. 12 * Adjusted Diluted EPS is a non-GAAP measure. See appendix.


Americas & Asia 13 • Revenues increased 10.7% in Q1 of F’25: • Organic growth = + 5.1%. • Fx decrease = (0.2%). • Acquisition = + 7.4% • Divestiture = (1.6%). • Organic sales grew 5.0% in the Americas with growth in all major product lines. • Organic sales grew 6.3% in Asia; growth throughout the region more than offset an organic sales decline in China. • Growth in segment profit due to organic sales growth in higher gross margin product lines, which was partially offset by certain acquisition-related costs and purchase accounting adjustments. Q1 F’25 SUMMARY:Q1 F’25 vs. Q1 F’24 (millions of USD) $218 $220 $223 $227 $222 $212 $225 $228 $245 19% 18% 22% 22% 23% 21% 22% 23% 22% 0% 5% 10% 15% 20% 25% $100 $150 $200 $250 $300 Q1 F'23 4.0% (1.4%) - Q2 F'23 6.9% (1.0%) - Q3 F'23 1.2% (0.8%) (0.3%) Q4 F'23 5.6% (0.2%) (1.0%) Q1 F'24 3.3% - (1.9%) Q2 F'24 1.2% 0.1% (5.1%) Q3 F'24 4.5% (0.1%) (3.5%) Q4 F'24 3.4% (0.8%) (2.2%) Q1 F'25 5.1% (0.2%) 5.8% SALES & SEGMENT PROFIT % (millions of USD) Q1 F’25 Q1 F’24 Change Sales $ 245.4 $ 221.6 10.7% Segment Profit 54.9 49.9 + 10.0% Segment Profit % 22.4% 22.5% - 10 bps • Organic sales growth in the low-single digit percentages in F’25. • Continued growth in segment profit. OUTLOOK: Organic For. Curr. Acq. & Div.


Europe & Australia 14 • Revenues increased 19.3% in Q1 of F’25: • Organic growth = 0.7%. • Fx increase = 3.6%. • Acquisition = 15.0% • Organic sales grew 1.1% in Europe primarily due to growth in the safety and facility identification and people identification product lines. • Organic sales declined 1.9% in Australia primarily due to a decline in the wire identification product line. • Segment profit decreased primarily due to acquisition-related costs and purchase accounting adjustments. Q1 F’25 SUMMARY:Q1 F’25 vs. Q4 F’24 (millions of USD) $104 $106 $114 $118 $110 $111 $119 $115 $132 16% 13% 15% 16% 15% 14% 16% 17% 10% 0% 5% 10% 15% $50 $75 $100 $125 $150 Q1 F'23 12.8% (17.0%) - Q2 F'23 5.2% (8.9%) - Q3 F'23 3.4% (4.8%) - Q4 F'23 9.5% 2.0% - Q1 F'24 1.4% 4.6% - Q2 F'24 2.5% 2.0% - Q3 F'24 4.4% (0.6%) - Q4 F'24 (1.8%) (1.2%) - Q1 F'25 0.7% 3.6% 15.0% SALES & SEGMENT PROFIT % Q1 F’25 Q1 F’24 Change Sales $ 131.6 $ 110.4 19.3% Segment Profit 13.1 16.7 (21.7%) Segment Profit % 10.0% 15.2% - 520 bps Organic For. Curr. Acquisitions • Organic sales growth in the low-single digit percentages in F’25. • Growth in segment profit. OUTLOOK: (millions of USD)


Investor Relations Brady Contact: Ann Thornton Investor Relations 414-438-6887 Ann_Thornton@bradycorp.com See our website at www.bradycorp.com/investors 15


Appendix GAAP to Non-GAAP Reconciliations


Non-GAAP Reconciliations 17 2024 2023 58,800$ 59,402$ Amortization expense 4,713 2,355 Non-recurring acquisition-related costs and other expenses 5,059 - 68,572$ 61,757$ 2024 2023 12,017$ 12,161$ Amortization expense 1,133 546 Non-recurring acquisition-related costs and other expenses 1,265 - 14,415$ 12,707$ GAAP to NON-GAAP MEASURES Adjusted Income Before Income Taxes: (Unaudited; Dollars in Thousands, Except Per Share Amounts) Brady is presenting the non-GAAP measure, "Adjusted Income Before Income Taxes." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Adjusted Income Before Income Taxes: Three months ended October 31, Income before income taxes (GAAP measure) In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. Adjusted Income Tax Expense (non-GAAP measure) Adjusted Income Before Income Taxes (non-GAAP measure) Income tax expense (GAAP measure) Adjusted Income Tax Expense: Brady is presenting the non-GAAP measure, "Adjusted Income Tax Expense." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Adjusted Income Tax Expense: Three months ended October 31,


Non-GAAP Reconciliations 18 2024 2023 46,783$ 47,241$ Amortization expense 3,580 1,809 Non-recurring acquisition-related costs and other expenses 3,794 - 54,157$ 49,050$ 2024 2023 $ 0.97 $ 0.97 Amortization expense 0.07 0.04 Non-recurring acquisition-related costs and other expenses 0.08 - 1.12$ 1.00$ Diluted EPS Excluding Certain Items Guidance: Low High Earnings per diluted Class A Common Share (GAAP measure) $ 4.02 $ 4.32 Amortization expense 0.30 0.30 Non-recurring acquisition-related costs and other expenses 0.08 0.08 Adjusted Diluted EPS (non-GAAP measure) 4.40$ 4.70$ Fiscal 2025 Expectations Adjusted Diluted EPS (non-GAAP measure) Adjusted Net Income (non-GAAP measure) Brady is presenting the non-GAAP measure, "Adjusted Net Income." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Adjusted Net Income: Net income (GAAP measure) Adjusted Diluted EPS: Three months ended October 31, Net income per Class A Nonvoting Common Share (GAAP measure) Three months ended October 31, Brady is presenting the non-GAAP measure, "Adjusted Diluted EPS." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Adjusted Diluted EPS (Note that certain amounts will not foot due to rounding): GAAP to NON-GAAP MEASURES (Unaudited; Dollars in Thousands, Except Per Share Amounts) Adjusted Net Income: In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.